PMA P150037S014

Device
CyPass Micro-Stent
Applicant
Alcon Research, Ltd.
PMA number
P150037
Supplement
S014
Product code
OGO
Decision date
2020-04-09
Generic name
Intraocular pressure lowering implant
Approval order statement
Approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the letter dated October 10, 2019 requesting that you continue the assessment of subjects implanted with the device for a minimum of 10 years to assess the long-term safety profile of the CyPass® System.

Current openFDA PMA Record#

Device
CyPass Micro-Stent
Applicant
Alcon Research, Ltd.
PMA number
P150037
Supplement
S014
Product code
OGO
Generic name
Intraocular pressure lowering implant
Decision date
2020-04-09
Decision code
APPR
Date received
2019-12-20
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Approval order statement
Approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the letter dated October 10, 2019 requesting that you continue the assessment of subjects implanted with the device for a minimum of 10 years to assess the long-term safety profile of the CyPass® System.